【Absolute antibody】重组抗体生产专家(二)
▍▏专注于小鼠体内免疫检查点研究的 VivopureX 系列重组抗体
Absolute Antibody 从大鼠或仓鼠获得最流行的克隆号抗体基因,通过其抗体测序、工程设计和重组表达的平台生产出原始抗原结合可变域和小鼠恒定域的嵌合抗体。
这样有效避免了在小鼠体内产生中和抗体,减少了抗体的使用,并且可以增加耗竭潜力或减少阻断的副作用。


货号 |
产品名 [Clone] |
反应种属 |
应用 |
Ab00813 |
Anti-PD-1 [RMP1-14] |
Mouse |
Blocking, FC, IHC-Fr |
Ab01258 |
Anti-TIGIT [1B4] |
Mouse |
Blocking, ELISA, FC |
Ab01295 |
Anti-Lag3 [C9B7W] |
Mouse |
Blocking, IP, FC |
Ab01490 |
Anti-IL-10R [1B1.3a] |
Mouse |
Blocking, FC |
Ab01090 |
Anti-B7-H4 [7A1-6] |
Mouse |
Blocking, FC, functional assays |
Ab01297 |
Anti-CD96 [6A6] |
Mouse |
Blocking, FC |
Ab01027 |
Anti-BTLA [HMBT-6B2] |
Mouse |
Blocking, functional assays, immunoblot, IP, WB, FC |
Ab01018 |
Anti-CTLA-4 [9D9] |
Mouse |
Agonist |
Ab00110 |
Anti-CD134 [OX86] |
Mouse |
Agonist, ELISA, FC, IF |
Ab01060 |
Anti-GITR [DTA-1] |
Mouse |
Agonist, IP, WB, FC |
Ab01107 |
Anti-CD25 [PC-61.5.3] |
Mouse |
Depletion, functional assays, WB, ELISA, FC, IF |
▍▏用于小鼠免疫检查点研究的其它抗体
针对免疫检查点相关蛋白质的抗体,它们与临床研究紧密相关。这些抗体同样可以通过抗体工程获得不同的物种,同种型和亚型,以及独特的形式(例如片段或双特异性)!


货号 |
产品名 [Clone] |
反应种属 |
应用 |
Ab00373 |
Anti-PDL1 [YDC 127.1.1] |
Mouse |
FC |
Ab00883 |
Anti-PD-L2 [TY25] |
Mouse |
IP, WB, Block, FC |
Ab01032 |
Anti-Tim-1 [3B3] |
Mouse |
Agonism, WB, FC, IF, IHC |
Ab01026 |
Anti-HVEM [HMHV-1B18] |
Mouse |
Blocking, functional assays, IP, WB, FC |
Ab01029 |
Anti-CD86 [PO.3] |
Mouse |
Blocking, functional assays, WB, FC, IHC |
Ab00816 |
Anti-CD70 [TAN 1-7] |
Mouse |
Block, ELISA, FC, IF |
Ab01060 |
Anti-GITR [DTA-1] |
Mouse |
Agonist, IP, WB, FC |
Ab00630 |
Anti-GITRL [YGL386] |
Mouse |
ELISA, FC |
Ab01109 |
Anti-CD40 [3/23] |
Mouse |
IP, FC, IHC |
Ab00814 |
Anti-ICOS [7.E.17G9] |
Mouse |
Block, FC |
Ab00882 |
Anti-ICOSL [HK5.3] |
Mouse |
Block, FC |
▍▏研究级生物仿制药
为了避免在研究和评估生物过程时购买昂贵的的治疗级生物仿制药,Absolute Antibody 生产了不含赋形剂和 / 或添加剂的研究级生物仿制药,是您实验阳性对照的最佳选择。
该类抗体除了仅针对人物种外,亦有针对人 + 小鼠 + 兔子 + 恒河猴 + 食蟹猴物种的抗体。

货号 |
产品名 [Clone] |
药名 |
反应种属 |
应用 |
Ab00449 |
Anti-alpha 5 beta 1 Integrin [M200 ] |
Volociximab |
Human |
Block, ELISA, FC, IF, IHC |
Ab00296 |
Anti-C5 |
Eculizumab |
Human |
Block, ELISA, EM |
Ab00281 |
Anti-carcinoembryonic antigen[CEA ] |
Arcitumomab |
Human |
IHC-P, FC, Imaging |
Ab00535 |
Anti-CD11a [hu1124 ] |
Efalizumab |
Human |
Block, FC |
Ab00194 |
Anti-CD25 [YTH 906.9HL ] |
Campath-6 |
Human |
IP, Block, FC |
Ab00122 |
Anti-CD3 epsilon [OKT-3 ] |
Muromonab |
Human |
FC |
Ab00283 |
Anti-CD33 [hP67.6] |
Gemtuzumab |
Human |
FC, IF |
Ab00282 |
Anti-CD41 [7E3] |
Abciximab |
Human |
Block, FC |
Ab00279 |
Anti-EGFR [C225] |
Cetuximab |
Human |
Block, FC |
Ab00103 |
Anti-erbB-2 (Her-2/neu) [4D5-8 ] |
Trastuzumab |
Human |
ELISA, FC, IHC |
Ab00717 |
Anti-IgE [huMaE11 ] |
Omalizumab |
Human |
Crystallization, Block, ELISA |
Ab00126 |
Anti-CD20 [10F381 ] |
Rituximab |
Human etc |
FC |
Ab00728 |
Anti-CD22 [hL22 ] |
Epratuzumab |
Human etc |
Blocking, IP, FC |
点在看,传递你的品味
